Lab Leasing | Biotech Expansion | CRE Capital | Innovation Districts

Toronto’s life sciences real estate market is at a turning point. Developers have delivered purpose-built lab space, but much of it remains vacant. Early-stage tenants are grappling with high buildout costs, tighter capital markets, and slow funding cycles. At the same time, major institutional players are circling, public-private partners are mobilizing, and academic institutions continue to produce world-class research. The question isn’t whether life sciences will grow, it’s who can actually take space, secure financing, and drive tenancy today. This event convenes real estate leaders, biotech execs, and innovation economy insiders to map out where the real opportunities are in 2026.